In a study by Shimamura et al. [25] in 2011, it was reported that fascin expression was significantly higher in dysplasia and oral carcinoma in situ (CIS) compared to benign diseases, including papilloma. This evidence concerns the gene FSCN1 and in situ carcinoma.